Prism Medico & Pharmacy has informed about disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for disposal of 129800 shares by the promoters group.
The above information is a part of company’s filings submitted to BSE.